IT8067262A0 - Agente anti ipercolesterolemico eprocedimento per la sua preparazione - Google Patents

Agente anti ipercolesterolemico eprocedimento per la sua preparazione

Info

Publication number
IT8067262A0
IT8067262A0 IT8067262A IT6726280A IT8067262A0 IT 8067262 A0 IT8067262 A0 IT 8067262A0 IT 8067262 A IT8067262 A IT 8067262A IT 6726280 A IT6726280 A IT 6726280A IT 8067262 A0 IT8067262 A0 IT 8067262A0
Authority
IT
Italy
Prior art keywords
procedure
preparation
hypercholesterolemic agent
anti hypercholesterolemic
agent
Prior art date
Application number
IT8067262A
Other languages
English (en)
Other versions
IT1175260B (it
Inventor
Akira Endo
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IT8067262A0 publication Critical patent/IT8067262A0/it
Application granted granted Critical
Publication of IT1175260B publication Critical patent/IT1175260B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IT67262/80A 1979-02-20 1980-02-20 Agente anti ipercolesterolemico e procedimento per la sua preparazione IT1175260B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (ja) 1979-02-20 1979-02-20 新生理活性物質モナコリンkおよびその製造法

Publications (2)

Publication Number Publication Date
IT8067262A0 true IT8067262A0 (it) 1980-02-20
IT1175260B IT1175260B (it) 1987-07-01

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67262/80A IT1175260B (it) 1979-02-20 1980-02-20 Agente anti ipercolesterolemico e procedimento per la sua preparazione

Country Status (27)

Country Link
JP (1) JPS5925599B2 (it)
KR (1) KR830002801B1 (it)
AT (1) AT373915B (it)
AU (1) AU532626B2 (it)
BE (1) BE881825A (it)
CA (1) CA1129794A (it)
CH (1) CH645890A5 (it)
DD (1) DD154494A5 (it)
DE (2) DE3006216C2 (it)
DK (2) DK149095C (it)
ES (1) ES488796A0 (it)
FI (1) FI66427C (it)
FR (1) FR2449685B1 (it)
GB (1) GB2046737B (it)
HU (1) HU182069B (it)
IE (1) IE49743B1 (it)
IT (1) IT1175260B (it)
MX (1) MX6314E (it)
NL (1) NL191540C (it)
NO (1) NO153974C (it)
NZ (1) NZ192919A (it)
PH (1) PH15145A (it)
PL (1) PL124304B1 (it)
SE (1) SE453301B (it)
SG (1) SG6784G (it)
SU (2) SU1158048A3 (it)
ZA (1) ZA80962B (it)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Mb−530a誘導体
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Mb−530b誘導体およびその製造法
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
EP0629184A1 (en) * 1992-03-04 1994-12-21 Fujisawa Pharmaceutical Co., Ltd. TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS
NZ247617A (en) 1992-05-15 1995-07-26 Sankyo Co Octahydronaphthalene oxime derivatives and pharmaceutical compositions
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
CZ300153B6 (cs) 1998-03-20 2009-02-25 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Metabolicky kontrolovaný proces fermentace pri výrobe lovastatinové hydroxykyseliny
JP3740062B2 (ja) 2000-02-24 2006-01-25 テバ ジョジセルジャール レースベニュタールシャシャーグ 培養液の精製方法
PL357533A1 (en) 2000-03-03 2004-07-26 Plus Chemicals, S.A. A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities
KR20010095780A (ko) * 2000-04-12 2001-11-07 나가오카 마사시 배아 홍국
IN192861B (it) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
AU2002235885A1 (en) 2001-02-09 2002-08-28 Unilever N.V. Process for the preparation of one or more statins by fermentation
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
KR100710500B1 (ko) 2005-05-18 2007-04-24 고려대학교 산학협력단 홍국균을 이용한 모나콜린 k 생산방법
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
WO2010069593A1 (en) 2008-12-19 2010-06-24 Krka, D. D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
RO128803A0 (ro) 2012-10-12 2013-09-30 Ion Gigel Fulga Compoziţie pentru tratamentul sau prevenirea dislipidemiilor
CN110331151A (zh) * 2019-04-11 2019-10-15 北京工商大学 紫色红曲菌mokH基因过表达菌株的构建方法
CN111297938A (zh) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 一种辅助降血脂组合物中洛伐他汀的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (it) 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
GR69216B (it) * 1979-06-15 1982-05-07 Merck & Co Inc

Also Published As

Publication number Publication date
FI66427C (fi) 1984-10-10
FR2449685A1 (fr) 1980-09-19
SG6784G (en) 1985-02-08
FI800506A (fi) 1980-08-21
AU532626B2 (en) 1983-10-06
DK149095C (da) 1986-06-16
SU1158048A3 (ru) 1985-05-23
DD154494A5 (de) 1982-03-24
JPS55111790A (en) 1980-08-28
HU182069B (en) 1983-12-28
SE8001339L (sv) 1980-08-21
DK73080A (da) 1980-08-21
DE3006216C2 (de) 1985-10-31
SE453301B (sv) 1988-01-25
ES8103171A1 (es) 1981-02-16
KR830002801B1 (ko) 1983-12-16
GB2046737B (en) 1983-01-12
PH15145A (en) 1982-08-24
PL222120A1 (it) 1980-10-20
NZ192919A (en) 1984-07-06
ZA80962B (en) 1981-03-25
GB2046737A (en) 1980-11-19
PL124304B1 (en) 1983-01-31
FI66427B (fi) 1984-06-29
IE800321L (en) 1980-08-20
ES488796A0 (es) 1981-02-16
DK21889A (da) 1989-01-18
IE49743B1 (en) 1985-12-11
NL8001041A (nl) 1980-08-22
ATA92980A (de) 1983-07-15
MX6314E (es) 1985-04-01
SU969702A1 (ru) 1982-10-30
IT1175260B (it) 1987-07-01
AT373915B (de) 1984-03-12
FR2449685B1 (fr) 1985-06-28
NO153974C (no) 1986-06-25
NL191540B (nl) 1995-05-01
DK21889D0 (da) 1989-01-18
DK149095B (da) 1986-01-20
DE3051175C2 (it) 1989-12-21
AU5567380A (en) 1980-08-28
DE3006216A1 (de) 1980-09-04
BE881825A (fr) 1980-08-20
CA1129794A (en) 1982-08-17
KR830002030A (ko) 1983-05-21
NO153974B (no) 1986-03-17
NO800451L (no) 1980-08-21
NL191540C (nl) 1995-09-04
JPS5925599B2 (ja) 1984-06-19
CH645890A5 (de) 1984-10-31

Similar Documents

Publication Publication Date Title
IT8067262A0 (it) Agente anti ipercolesterolemico eprocedimento per la sua preparazione
GB2072843B (en) Blood serum-separating agent
ES490110A0 (es) Procedimiento de preparar aril-3 ester-5 oxazolidinonas-2 y oxazolidinationas-2 nuevas
ES494634A0 (es) Procedimiento para la preparacion de compuestos de cefem y cefam
MX5676E (es) Procedimiento mejorado para la preparacion de cicloalcanoles y cicloalcanonas
IT1129802B (it) Agente antitumorale
IT1084178B (it) Poli-di carbo-monofluoruro e procedimento per la sua preparazione
IT1119922B (it) Sostanza anti tumorale e procedimento per la sua preparazione
IT1130944B (it) Agente disaprettante e processo per la sua preparazione
BR8005664A (pt) Esteres quaternarios de hidroxialquilamidoaminas,processos para sua preparacao e sua aplicacao
AR220383A1 (es) Procedimiento para la preparacion de 2,3,5,6-tetracloropiridina y pentacloropiridina
IT8048889A0 (it) Composti perfluoroalchilici e procedimento per prepararli
IT1141591B (it) Prodotto disinfestante e procedimento per la sua preparazione
MX6217E (es) Procedimiento para la preparacion de 4,1-benzoxazepinas y 4,1-benzotiazepinas
ES488513A0 (es) Procedimiento para la preparacion de fenoxi y tiofenoxinitrilos.
IT1146125B (it) Manica filtrante e procedimento per la sua fabbricazione
ES495814A0 (es) Procedimiento de desempolvado de particulas
ES480979A0 (es) Procedimiento de pre-paracion de compuestos opacificantes para radiografia y similares.
IT8083454A0 (it) Harzburgite e procedimento per lapreparazione della stessa.
IT1165040B (it) Alcossialchilidenidrazinopiridazione e procedimento per la loro preparazione
IT1118225B (it) Procedimento per l'ottenimento di steroidi poliossidrilati,lisergolo ed alcaloidi ergolici
ES489115A0 (es) Procedimiento de preparacion de polieteres glicidicos de po-lifenoles
IT1141632B (it) Antibiotico marcrolidico e procedimento per la sua preparazione
IT1117409B (it) Procedimento per depurare etildiclicole e dipropilenglicole
IT1129501B (it) Procedimento e dispositivo per la preparazione per precipitazioni-flottazione di rottami di accumulatori

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227